Neurovascular Thrombectomy Device-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Neurovascular Thrombectomy Device-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Neurovascular Thrombectomy Device industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Neurovascular Thrombectomy Device 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Neurovascular Thrombectomy Device worldwide and market share by regions, with company and product introduction, position in the Neurovascular Thrombectomy Device market
Market status and development trend of Neurovascular Thrombectomy Device by types and applications
Cost and profit status of Neurovascular Thrombectomy Device, and marketing status
Market growth drivers and challenges
The report segments the global Neurovascular Thrombectomy Device market as:
Global Neurovascular Thrombectomy Device Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Neurovascular Thrombectomy Device Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Mechanical/Fragmentation Thrombectomy Devices
Stent Retrievers
Basket/Brush Retrievers
Coil Retrievers
Aspiration Thrombectomy Devices
Rheolytic/Hydrodynamic Thrombectomy Devices
Ultrasonic Thrombectomy Devices
Global Neurovascular Thrombectomy Device Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals and Surgical Centers
Ambulatory Surgical Centers
Research Laboratories & Academic Institutes
Others
Global Neurovascular Thrombectomy Device Market: Manufacturers Segment Analysis (Company and Product introduction, Neurovascular Thrombectomy Device Sales Volume, Revenue, Price and Gross Margin):
Stryker Corporation (U.S.)
Medtronic plc (Ireland)
Boston Scientific Corporation (U.S.)
Johnson & Johnson (U.S.)
Terumo Corporation (Japan)
Penumbra, Inc. (U.S.)
Spectranetics Corporation (U.S.)
Edwards Lifesciences Corporation (U.S.)
Argon Medical Devices, Inc. (U.S.)
Teleflex Incorporated (U.S.)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Neurovascular Thrombectomy Device-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Neurovascular Thrombectomy Device industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Neurovascular Thrombectomy Device 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Neurovascular Thrombectomy Device worldwide and market share by regions, with company and product introduction, position in the Neurovascular Thrombectomy Device market
Market status and development trend of Neurovascular Thrombectomy Device by types and applications
Cost and profit status of Neurovascular Thrombectomy Device, and marketing status
Market growth drivers and challenges
The report segments the global Neurovascular Thrombectomy Device market as:
Global Neurovascular Thrombectomy Device Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Neurovascular Thrombectomy Device Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Mechanical/Fragmentation Thrombectomy Devices
Stent Retrievers
Basket/Brush Retrievers
Coil Retrievers
Aspiration Thrombectomy Devices
Rheolytic/Hydrodynamic Thrombectomy Devices
Ultrasonic Thrombectomy Devices
Global Neurovascular Thrombectomy Device Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals and Surgical Centers
Ambulatory Surgical Centers
Research Laboratories & Academic Institutes
Others
Global Neurovascular Thrombectomy Device Market: Manufacturers Segment Analysis (Company and Product introduction, Neurovascular Thrombectomy Device Sales Volume, Revenue, Price and Gross Margin):
Stryker Corporation (U.S.)
Medtronic plc (Ireland)
Boston Scientific Corporation (U.S.)
Johnson & Johnson (U.S.)
Terumo Corporation (Japan)
Penumbra, Inc. (U.S.)
Spectranetics Corporation (U.S.)
Edwards Lifesciences Corporation (U.S.)
Argon Medical Devices, Inc. (U.S.)
Teleflex Incorporated (U.S.)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF NEUROVASCULAR THROMBECTOMY DEVICE
1.1 Definition of Neurovascular Thrombectomy Device in This Report
1.2 Commercial Types of Neurovascular Thrombectomy Device
1.2.1 Mechanical/Fragmentation Thrombectomy Devices
1.2.2 Stent Retrievers
1.2.3 Basket/Brush Retrievers
1.2.4 Coil Retrievers
1.2.5 Aspiration Thrombectomy Devices
1.2.6 Rheolytic/Hydrodynamic Thrombectomy Devices
1.2.7 Ultrasonic Thrombectomy Devices
1.3 Downstream Application of Neurovascular Thrombectomy Device
1.3.1 Hospitals and Surgical Centers
1.3.2 Ambulatory Surgical Centers
1.3.3 Research Laboratories & Academic Institutes
1.3.4 Others
1.4 Development History of Neurovascular Thrombectomy Device
1.5 Market Status and Trend of Neurovascular Thrombectomy Device 2013-2023
1.5.1 Global Neurovascular Thrombectomy Device Market Status and Trend 2013-2023
1.5.2 Regional Neurovascular Thrombectomy Device Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Neurovascular Thrombectomy Device 2013-2017
2.2 Sales Market of Neurovascular Thrombectomy Device by Regions
2.2.1 Sales Volume of Neurovascular Thrombectomy Device by Regions
2.2.2 Sales Value of Neurovascular Thrombectomy Device by Regions
2.3 Production Market of Neurovascular Thrombectomy Device by Regions
2.4 Global Market Forecast of Neurovascular Thrombectomy Device 2018-2023
2.4.1 Global Market Forecast of Neurovascular Thrombectomy Device 2018-2023
2.4.2 Market Forecast of Neurovascular Thrombectomy Device by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Neurovascular Thrombectomy Device by Types
3.2 Sales Value of Neurovascular Thrombectomy Device by Types
3.3 Market Forecast of Neurovascular Thrombectomy Device by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Neurovascular Thrombectomy Device by Downstream Industry
4.2 Global Market Forecast of Neurovascular Thrombectomy Device by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Neurovascular Thrombectomy Device Market Status by Countries
5.1.1 North America Neurovascular Thrombectomy Device Sales by Countries (2013-2017)
5.1.2 North America Neurovascular Thrombectomy Device Revenue by Countries (2013-2017)
5.1.3 United States Neurovascular Thrombectomy Device Market Status (2013-2017)
5.1.4 Canada Neurovascular Thrombectomy Device Market Status (2013-2017)
5.1.5 Mexico Neurovascular Thrombectomy Device Market Status (2013-2017)
5.2 North America Neurovascular Thrombectomy Device Market Status by Manufacturers
5.3 North America Neurovascular Thrombectomy Device Market Status by Type (2013-2017)
5.3.1 North America Neurovascular Thrombectomy Device Sales by Type (2013-2017)
5.3.2 North America Neurovascular Thrombectomy Device Revenue by Type (2013-2017)
5.4 North America Neurovascular Thrombectomy Device Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Neurovascular Thrombectomy Device Market Status by Countries
6.1.1 Europe Neurovascular Thrombectomy Device Sales by Countries (2013-2017)
6.1.2 Europe Neurovascular Thrombectomy Device Revenue by Countries (2013-2017)
6.1.3 Germany Neurovascular Thrombectomy Device Market Status (2013-2017)
6.1.4 UK Neurovascular Thrombectomy Device Market Status (2013-2017)
6.1.5 France Neurovascular Thrombectomy Device Market Status (2013-2017)
6.1.6 Italy Neurovascular Thrombectomy Device Market Status (2013-2017)
6.1.7 Russia Neurovascular Thrombectomy Device Market Status (2013-2017)
6.1.8 Spain Neurovascular Thrombectomy Device Market Status (2013-2017)
6.1.9 Benelux Neurovascular Thrombectomy Device Market Status (2013-2017)
6.2 Europe Neurovascular Thrombectomy Device Market Status by Manufacturers
6.3 Europe Neurovascular Thrombectomy Device Market Status by Type (2013-2017)
6.3.1 Europe Neurovascular Thrombectomy Device Sales by Type (2013-2017)
6.3.2 Europe Neurovascular Thrombectomy Device Revenue by Type (2013-2017)
6.4 Europe Neurovascular Thrombectomy Device Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Neurovascular Thrombectomy Device Market Status by Countries
7.1.1 Asia Pacific Neurovascular Thrombectomy Device Sales by Countries (2013-2017)
7.1.2 Asia Pacific Neurovascular Thrombectomy Device Revenue by Countries (2013-2017)
7.1.3 China Neurovascular Thrombectomy Device Market Status (2013-2017)
7.1.4 Japan Neurovascular Thrombectomy Device Market Status (2013-2017)
7.1.5 India Neurovascular Thrombectomy Device Market Status (2013-2017)
7.1.6 Southeast Asia Neurovascular Thrombectomy Device Market Status (2013-2017)
7.1.7 Australia Neurovascular Thrombectomy Device Market Status (2013-2017)
7.2 Asia Pacific Neurovascular Thrombectomy Device Market Status by Manufacturers
7.3 Asia Pacific Neurovascular Thrombectomy Device Market Status by Type (2013-2017)
7.3.1 Asia Pacific Neurovascular Thrombectomy Device Sales by Type (2013-2017)
7.3.2 Asia Pacific Neurovascular Thrombectomy Device Revenue by Type (2013-2017)
7.4 Asia Pacific Neurovascular Thrombectomy Device Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Neurovascular Thrombectomy Device Market Status by Countries
8.1.1 Latin America Neurovascular Thrombectomy Device Sales by Countries (2013-2017)
8.1.2 Latin America Neurovascular Thrombectomy Device Revenue by Countries (2013-2017)
8.1.3 Brazil Neurovascular Thrombectomy Device Market Status (2013-2017)
8.1.4 Argentina Neurovascular Thrombectomy Device Market Status (2013-2017)
8.1.5 Colombia Neurovascular Thrombectomy Device Market Status (2013-2017)
8.2 Latin America Neurovascular Thrombectomy Device Market Status by Manufacturers
8.3 Latin America Neurovascular Thrombectomy Device Market Status by Type (2013-2017)
8.3.1 Latin America Neurovascular Thrombectomy Device Sales by Type (2013-2017)
8.3.2 Latin America Neurovascular Thrombectomy Device Revenue by Type (2013-2017)
8.4 Latin America Neurovascular Thrombectomy Device Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Neurovascular Thrombectomy Device Market Status by Countries
9.1.1 Middle East and Africa Neurovascular Thrombectomy Device Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Neurovascular Thrombectomy Device Revenue by Countries (2013-2017)
9.1.3 Middle East Neurovascular Thrombectomy Device Market Status (2013-2017)
9.1.4 Africa Neurovascular Thrombectomy Device Market Status (2013-2017)
9.2 Middle East and Africa Neurovascular Thrombectomy Device Market Status by Manufacturers
9.3 Middle East and Africa Neurovascular Thrombectomy Device Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Neurovascular Thrombectomy Device Sales by Type (2013-2017)
9.3.2 Middle East and Africa Neurovascular Thrombectomy Device Revenue by Type (2013-2017)
9.4 Middle East and Africa Neurovascular Thrombectomy Device Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF NEUROVASCULAR THROMBECTOMY DEVICE
10.1 Global Economy Situation and Trend Overview
10.2 Neurovascular Thrombectomy Device Downstream Industry Situation and Trend Overview
CHAPTER 11 NEUROVASCULAR THROMBECTOMY DEVICE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Neurovascular Thrombectomy Device by Major Manufacturers
11.2 Production Value of Neurovascular Thrombectomy Device by Major Manufacturers
11.3 Basic Information of Neurovascular Thrombectomy Device by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Neurovascular Thrombectomy Device Major Manufacturer
11.3.2 Employees and Revenue Level of Neurovascular Thrombectomy Device Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 NEUROVASCULAR THROMBECTOMY DEVICE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Stryker Corporation (U.S.)
12.1.1 Company profile
12.1.2 Representative Neurovascular Thrombectomy Device Product
12.1.3 Neurovascular Thrombectomy Device Sales, Revenue, Price and Gross Margin of Stryker Corporation (U.S.)
12.2 Medtronic plc (Ireland)
12.2.1 Company profile
12.2.2 Representative Neurovascular Thrombectomy Device Product
12.2.3 Neurovascular Thrombectomy Device Sales, Revenue, Price and Gross Margin of Medtronic plc (Ireland)
12.3 Boston Scientific Corporation (U.S.)
12.3.1 Company profile
12.3.2 Representative Neurovascular Thrombectomy Device Product
12.3.3 Neurovascular Thrombectomy Device Sales, Revenue, Price and Gross Margin of Boston Scientific Corporation (U.S.)
12.4 Johnson & Johnson (U.S.)
12.4.1 Company profile
12.4.2 Representative Neurovascular Thrombectomy Device Product
12.4.3 Neurovascular Thrombectomy Device Sales, Revenue, Price and Gross Margin of Johnson & Johnson (U.S.)
12.5 Terumo Corporation (Japan)
12.5.1 Company profile
12.5.2 Representative Neurovascular Thrombectomy Device Product
12.5.3 Neurovascular Thrombectomy Device Sales, Revenue, Price and Gross Margin of Terumo Corporation (Japan)
12.6 Penumbra, Inc. (U.S.)
12.6.1 Company profile
12.6.2 Representative Neurovascular Thrombectomy Device Product
12.6.3 Neurovascular Thrombectomy Device Sales, Revenue, Price and Gross Margin of Penumbra, Inc. (U.S.)
12.7 Spectranetics Corporation (U.S.)
12.7.1 Company profile
12.7.2 Representative Neurovascular Thrombectomy Device Product
12.7.3 Neurovascular Thrombectomy Device Sales, Revenue, Price and Gross Margin of Spectranetics Corporation (U.S.)
12.8 Edwards Lifesciences Corporation (U.S.)
12.8.1 Company profile
12.8.2 Representative Neurovascular Thrombectomy Device Product
12.8.3 Neurovascular Thrombectomy Device Sales, Revenue, Price and Gross Margin of Edwards Lifesciences Corporation (U.S.)
12.9 Argon Medical Devices, Inc. (U.S.)
12.9.1 Company profile
12.9.2 Representative Neurovascular Thrombectomy Device Product
12.9.3 Neurovascular Thrombectomy Device Sales, Revenue, Price and Gross Margin of Argon Medical Devices, Inc. (U.S.)
12.10 Teleflex Incorporated (U.S.)
12.10.1 Company profile
12.10.2 Representative Neurovascular Thrombectomy Device Product
12.10.3 Neurovascular Thrombectomy Device Sales, Revenue, Price and Gross Margin of Teleflex Incorporated (U.S.)
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NEUROVASCULAR THROMBECTOMY DEVICE
13.1 Industry Chain of Neurovascular Thrombectomy Device
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF NEUROVASCULAR THROMBECTOMY DEVICE
14.1 Cost Structure Analysis of Neurovascular Thrombectomy Device
14.2 Raw Materials Cost Analysis of Neurovascular Thrombectomy Device
14.3 Labor Cost Analysis of Neurovascular Thrombectomy Device
14.4 Manufacturing Expenses Analysis of Neurovascular Thrombectomy Device
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Neurovascular Thrombectomy Device in This Report
1.2 Commercial Types of Neurovascular Thrombectomy Device
1.2.1 Mechanical/Fragmentation Thrombectomy Devices
1.2.2 Stent Retrievers
1.2.3 Basket/Brush Retrievers
1.2.4 Coil Retrievers
1.2.5 Aspiration Thrombectomy Devices
1.2.6 Rheolytic/Hydrodynamic Thrombectomy Devices
1.2.7 Ultrasonic Thrombectomy Devices
1.3 Downstream Application of Neurovascular Thrombectomy Device
1.3.1 Hospitals and Surgical Centers
1.3.2 Ambulatory Surgical Centers
1.3.3 Research Laboratories & Academic Institutes
1.3.4 Others
1.4 Development History of Neurovascular Thrombectomy Device
1.5 Market Status and Trend of Neurovascular Thrombectomy Device 2013-2023
1.5.1 Global Neurovascular Thrombectomy Device Market Status and Trend 2013-2023
1.5.2 Regional Neurovascular Thrombectomy Device Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Neurovascular Thrombectomy Device 2013-2017
2.2 Sales Market of Neurovascular Thrombectomy Device by Regions
2.2.1 Sales Volume of Neurovascular Thrombectomy Device by Regions
2.2.2 Sales Value of Neurovascular Thrombectomy Device by Regions
2.3 Production Market of Neurovascular Thrombectomy Device by Regions
2.4 Global Market Forecast of Neurovascular Thrombectomy Device 2018-2023
2.4.1 Global Market Forecast of Neurovascular Thrombectomy Device 2018-2023
2.4.2 Market Forecast of Neurovascular Thrombectomy Device by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Neurovascular Thrombectomy Device by Types
3.2 Sales Value of Neurovascular Thrombectomy Device by Types
3.3 Market Forecast of Neurovascular Thrombectomy Device by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Neurovascular Thrombectomy Device by Downstream Industry
4.2 Global Market Forecast of Neurovascular Thrombectomy Device by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Neurovascular Thrombectomy Device Market Status by Countries
5.1.1 North America Neurovascular Thrombectomy Device Sales by Countries (2013-2017)
5.1.2 North America Neurovascular Thrombectomy Device Revenue by Countries (2013-2017)
5.1.3 United States Neurovascular Thrombectomy Device Market Status (2013-2017)
5.1.4 Canada Neurovascular Thrombectomy Device Market Status (2013-2017)
5.1.5 Mexico Neurovascular Thrombectomy Device Market Status (2013-2017)
5.2 North America Neurovascular Thrombectomy Device Market Status by Manufacturers
5.3 North America Neurovascular Thrombectomy Device Market Status by Type (2013-2017)
5.3.1 North America Neurovascular Thrombectomy Device Sales by Type (2013-2017)
5.3.2 North America Neurovascular Thrombectomy Device Revenue by Type (2013-2017)
5.4 North America Neurovascular Thrombectomy Device Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Neurovascular Thrombectomy Device Market Status by Countries
6.1.1 Europe Neurovascular Thrombectomy Device Sales by Countries (2013-2017)
6.1.2 Europe Neurovascular Thrombectomy Device Revenue by Countries (2013-2017)
6.1.3 Germany Neurovascular Thrombectomy Device Market Status (2013-2017)
6.1.4 UK Neurovascular Thrombectomy Device Market Status (2013-2017)
6.1.5 France Neurovascular Thrombectomy Device Market Status (2013-2017)
6.1.6 Italy Neurovascular Thrombectomy Device Market Status (2013-2017)
6.1.7 Russia Neurovascular Thrombectomy Device Market Status (2013-2017)
6.1.8 Spain Neurovascular Thrombectomy Device Market Status (2013-2017)
6.1.9 Benelux Neurovascular Thrombectomy Device Market Status (2013-2017)
6.2 Europe Neurovascular Thrombectomy Device Market Status by Manufacturers
6.3 Europe Neurovascular Thrombectomy Device Market Status by Type (2013-2017)
6.3.1 Europe Neurovascular Thrombectomy Device Sales by Type (2013-2017)
6.3.2 Europe Neurovascular Thrombectomy Device Revenue by Type (2013-2017)
6.4 Europe Neurovascular Thrombectomy Device Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Neurovascular Thrombectomy Device Market Status by Countries
7.1.1 Asia Pacific Neurovascular Thrombectomy Device Sales by Countries (2013-2017)
7.1.2 Asia Pacific Neurovascular Thrombectomy Device Revenue by Countries (2013-2017)
7.1.3 China Neurovascular Thrombectomy Device Market Status (2013-2017)
7.1.4 Japan Neurovascular Thrombectomy Device Market Status (2013-2017)
7.1.5 India Neurovascular Thrombectomy Device Market Status (2013-2017)
7.1.6 Southeast Asia Neurovascular Thrombectomy Device Market Status (2013-2017)
7.1.7 Australia Neurovascular Thrombectomy Device Market Status (2013-2017)
7.2 Asia Pacific Neurovascular Thrombectomy Device Market Status by Manufacturers
7.3 Asia Pacific Neurovascular Thrombectomy Device Market Status by Type (2013-2017)
7.3.1 Asia Pacific Neurovascular Thrombectomy Device Sales by Type (2013-2017)
7.3.2 Asia Pacific Neurovascular Thrombectomy Device Revenue by Type (2013-2017)
7.4 Asia Pacific Neurovascular Thrombectomy Device Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Neurovascular Thrombectomy Device Market Status by Countries
8.1.1 Latin America Neurovascular Thrombectomy Device Sales by Countries (2013-2017)
8.1.2 Latin America Neurovascular Thrombectomy Device Revenue by Countries (2013-2017)
8.1.3 Brazil Neurovascular Thrombectomy Device Market Status (2013-2017)
8.1.4 Argentina Neurovascular Thrombectomy Device Market Status (2013-2017)
8.1.5 Colombia Neurovascular Thrombectomy Device Market Status (2013-2017)
8.2 Latin America Neurovascular Thrombectomy Device Market Status by Manufacturers
8.3 Latin America Neurovascular Thrombectomy Device Market Status by Type (2013-2017)
8.3.1 Latin America Neurovascular Thrombectomy Device Sales by Type (2013-2017)
8.3.2 Latin America Neurovascular Thrombectomy Device Revenue by Type (2013-2017)
8.4 Latin America Neurovascular Thrombectomy Device Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Neurovascular Thrombectomy Device Market Status by Countries
9.1.1 Middle East and Africa Neurovascular Thrombectomy Device Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Neurovascular Thrombectomy Device Revenue by Countries (2013-2017)
9.1.3 Middle East Neurovascular Thrombectomy Device Market Status (2013-2017)
9.1.4 Africa Neurovascular Thrombectomy Device Market Status (2013-2017)
9.2 Middle East and Africa Neurovascular Thrombectomy Device Market Status by Manufacturers
9.3 Middle East and Africa Neurovascular Thrombectomy Device Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Neurovascular Thrombectomy Device Sales by Type (2013-2017)
9.3.2 Middle East and Africa Neurovascular Thrombectomy Device Revenue by Type (2013-2017)
9.4 Middle East and Africa Neurovascular Thrombectomy Device Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF NEUROVASCULAR THROMBECTOMY DEVICE
10.1 Global Economy Situation and Trend Overview
10.2 Neurovascular Thrombectomy Device Downstream Industry Situation and Trend Overview
CHAPTER 11 NEUROVASCULAR THROMBECTOMY DEVICE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Neurovascular Thrombectomy Device by Major Manufacturers
11.2 Production Value of Neurovascular Thrombectomy Device by Major Manufacturers
11.3 Basic Information of Neurovascular Thrombectomy Device by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Neurovascular Thrombectomy Device Major Manufacturer
11.3.2 Employees and Revenue Level of Neurovascular Thrombectomy Device Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 NEUROVASCULAR THROMBECTOMY DEVICE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Stryker Corporation (U.S.)
12.1.1 Company profile
12.1.2 Representative Neurovascular Thrombectomy Device Product
12.1.3 Neurovascular Thrombectomy Device Sales, Revenue, Price and Gross Margin of Stryker Corporation (U.S.)
12.2 Medtronic plc (Ireland)
12.2.1 Company profile
12.2.2 Representative Neurovascular Thrombectomy Device Product
12.2.3 Neurovascular Thrombectomy Device Sales, Revenue, Price and Gross Margin of Medtronic plc (Ireland)
12.3 Boston Scientific Corporation (U.S.)
12.3.1 Company profile
12.3.2 Representative Neurovascular Thrombectomy Device Product
12.3.3 Neurovascular Thrombectomy Device Sales, Revenue, Price and Gross Margin of Boston Scientific Corporation (U.S.)
12.4 Johnson & Johnson (U.S.)
12.4.1 Company profile
12.4.2 Representative Neurovascular Thrombectomy Device Product
12.4.3 Neurovascular Thrombectomy Device Sales, Revenue, Price and Gross Margin of Johnson & Johnson (U.S.)
12.5 Terumo Corporation (Japan)
12.5.1 Company profile
12.5.2 Representative Neurovascular Thrombectomy Device Product
12.5.3 Neurovascular Thrombectomy Device Sales, Revenue, Price and Gross Margin of Terumo Corporation (Japan)
12.6 Penumbra, Inc. (U.S.)
12.6.1 Company profile
12.6.2 Representative Neurovascular Thrombectomy Device Product
12.6.3 Neurovascular Thrombectomy Device Sales, Revenue, Price and Gross Margin of Penumbra, Inc. (U.S.)
12.7 Spectranetics Corporation (U.S.)
12.7.1 Company profile
12.7.2 Representative Neurovascular Thrombectomy Device Product
12.7.3 Neurovascular Thrombectomy Device Sales, Revenue, Price and Gross Margin of Spectranetics Corporation (U.S.)
12.8 Edwards Lifesciences Corporation (U.S.)
12.8.1 Company profile
12.8.2 Representative Neurovascular Thrombectomy Device Product
12.8.3 Neurovascular Thrombectomy Device Sales, Revenue, Price and Gross Margin of Edwards Lifesciences Corporation (U.S.)
12.9 Argon Medical Devices, Inc. (U.S.)
12.9.1 Company profile
12.9.2 Representative Neurovascular Thrombectomy Device Product
12.9.3 Neurovascular Thrombectomy Device Sales, Revenue, Price and Gross Margin of Argon Medical Devices, Inc. (U.S.)
12.10 Teleflex Incorporated (U.S.)
12.10.1 Company profile
12.10.2 Representative Neurovascular Thrombectomy Device Product
12.10.3 Neurovascular Thrombectomy Device Sales, Revenue, Price and Gross Margin of Teleflex Incorporated (U.S.)
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NEUROVASCULAR THROMBECTOMY DEVICE
13.1 Industry Chain of Neurovascular Thrombectomy Device
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF NEUROVASCULAR THROMBECTOMY DEVICE
14.1 Cost Structure Analysis of Neurovascular Thrombectomy Device
14.2 Raw Materials Cost Analysis of Neurovascular Thrombectomy Device
14.3 Labor Cost Analysis of Neurovascular Thrombectomy Device
14.4 Manufacturing Expenses Analysis of Neurovascular Thrombectomy Device
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
